Tuberculosis Rapid Diagnostic Test

PATHFAST™ TB LAM Ag test is a product for in vitro diagnostic use with the PATHFAST™ automated analyser for the quantitative measurement of lipoarabinomannan (LAM) in human sputum. PATHFAST™ TB LAM Ag test is intended to be used:

as an aid to the diagnosis of TB

by laboratory technician, nurse or physician

in a hospital or clinical laboratory setting.

The PATHFAST™ TB LAM Ag test procedure is based on a chemiluminescent enzyme immunoassay and MAGTRATION*. All required components for performing the testing are packed in one reagent cartridge.

By loading PATHFAST™ TB LAM Ag cartridge into the in vitro diagnostic system PATHFAST™, the quantification of LAM can be accurately measured within 17 minutes.

LAM is a 17.5 kDa glycolipid present in the mycobacterial cell wall [6] . LAM can be detected in the sputum of TB patients, and LAM concentration correlates well with the score of smear microscopy and time to detect of a culture

Benefits of choosing PATHFAST™ TB LAM Ag test

PATHFAST™ TB LAM Ag test stands out with many benefits for TB treatment monitoring due to its numerous competitive advantages.

Minimal containment requirements: It doesn't demand high-level biosafety containment (e.g. BSL3 lab), making it ideal for resource-limited settings.

Ease of use: Its straightforward operation that requires minimal training, streamlining workflow.

Quantitative precision: It provides quantitative results allowing for a deeper understanding of TB treatment efficacy.

High sensitivity: It detects lower LAM concentrations, enabling TB treatment monitoring also in patients with low bacterial loads.